According to the OECD recently released its OECD Health Data 2011 report, healthcare spending continues to rise faster than economic growth in most OECD countries. Healthcare spending reached 9.5% of GDP on average in 2009, up from 8.8% in 2008. As expected the U.S. continues to spend the most on healthcare. The following chart shows …
Continue reading ‘Healthcare Expenditure as a Share of GDP Among OECD Countries 2009’ »
Healthcare spending is about 9% of GDP on average in OECD countries. However in many countries it exceeds 10% of the GDP. Over three quarters of healthcare spending is publicly funded. The current economic crisis, ageing populations, rising budget deficits, soaring healthcare costs and other factors are forcing healthcare spending to be tightened in most …
Continue reading ‘Comparison of Healthcare Expenditure Across OECD Countries’ »
New York city-based The Commonwealth Fund published a report few months ago comparing the the U.S. to six other developed countries on measures of healthcare performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives. The countries compared were Australia, Canada, Germany, the Netherlands, New Zealand, …
Continue reading ‘Comparison of Healthcare Performance Among Seven Countries – U.S. Ranks Last’ »
On March 23, 2010 President Barack Obama signed the historic healthcare reform bill into law. This marked the end of many months of wrangling between the Republicans and Democrats. The $938 Billion bill brings many significant changes to the US healthcare system in decades. The $938B bill would be financed by tax increases and reduction …
Continue reading ‘U.S. Healthcare Reform is a Big Boon For Healthcare Companies’ »
In a recent article I wrote that U.S. public healthcare spending is projected to exceed private spending by 2012. U.S. healthcare expenditures was estimated to reach about 17.3% of the GDP in 2009. One of the beneficiaries of all this spending are the companies in the healthcare industry such drug makers, health insurers, etc. They …
Continue reading ‘Drug Stocks Offer Long-Term Investment Opportunities’ »